Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids-Reference-Cited by-同舟云学术

Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids

Published:2014 Issue: Volume:1 Page:14024
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Burnett Ryan,Ibañez Carlos E.,Pettersson Pär L.,Chen Ching-I,Parab Shraddha,Huang Tiffany,Robbins Joan,Bankiewicz Krystof,Aghi Manish,Logg Christopher,Kasahara Noriyuki,Pertschuk Dan,Gruber Harry E.,Jolly Douglas J.

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference24 articles.

1. Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression;Perez;Mol Ther,2012

2. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma;Tai;Mol Ther,2005

3. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector;Ostertag;Neuro Oncol,2012

4. Replication-competent retrovirus vectors for cancer gene therapy;Tai;Front Biosci,2008

5. Experimental and clinical use of fluorinated pyrimidines in cancer chemotherapy;Heidelberger;Cancer Res,1963

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction;Brain Research;2019-11